Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hippo Holdings (HIPO) Research & Development (2020 - 2025)

Hippo Holdings (HIPO) has disclosed Research & Development for 6 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 14.29% year-over-year to $8.0 million, compared with a TTM value of $31.8 million through Sep 2025, down 5.07%, and an annual FY2024 reading of $30.7 million, down 34.68% over the prior year.
  • Research & Development was $8.0 million for Q3 2025 at Hippo Holdings, down from $8.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $16.5 million in Q2 2022 and bottomed at $6.9 million in Q1 2021.
  • Average Research & Development over 5 years is $10.3 million, with a median of $8.3 million recorded in 2021.
  • The sharpest move saw Research & Development skyrocketed 117.11% in 2022, then plummeted 41.18% in 2024.
  • Year by year, Research & Development stood at $13.4 million in 2021, then dropped by 14.18% to $11.5 million in 2022, then fell by 9.57% to $10.4 million in 2023, then fell by 26.92% to $7.6 million in 2024, then rose by 5.26% to $8.0 million in 2025.
  • Business Quant data shows Research & Development for HIPO at $8.0 million in Q3 2025, $8.1 million in Q2 2025, and $8.1 million in Q1 2025.